Ain Holdings Inc. · TSE:9627

Ain — Q2 FY4/24 Earnings Presentation

30 slides from Ain's earnings presentation, December 2023

  1. Slide 1: FY4/24 2Q IR Presentation

    FY4/24 2Q IR PRESENTATION December 2023

  2. Slide 2: Results Overview

    Results Overview © 2023 AIN HOLDINGS INC. All Rights Reserved. 1

  3. Slide 3: Consolidated P/L

    Consolidated P/L Net sales increased 13.2% YoY and 5.6% against the plan due to favorable performance in both dispensing pharmacy business and cosmetic and drag store business. Ordinary profit increased 28.2% YoY and 45.4% against the plan due to increase of sales. FY4/23 2Q FY4/24 2Q FY4/24 2Q YoY

  4. Slide 4: Dispensing Pharmacy Business (Consolidated)

    Dispensing Pharmacy Business (Consolidated) Net sales increased 13.0% YoY and 5.4% against the plan due to rise in prescription numbers and average price because of improvements in the capabilities of primary care functions in addition to the easing of restrictions on outpatient visits and an early

  5. Slide 5: Cosmetic and Drug Store Business (Consolidated)

    Cosmetic and Drug Store Business (Consolidated) Net sales up 21.5% YoY and 10.4% against the plan due to recovery in mobility and a change in customer buying habits to cosmetics. Segment profit increased 277.7% YoY and 139.6% against the plan due to increase of sales. FY4/23 2Q FY4/24 2Q FY4/24 2Q Y

  6. Slide 6: Consolidated B/S

    Consolidated B/S Net cash became ¥43,578 million and shareholdersʼ equity ratio became 53.4%. We are maintaining a sound financial structure. End-FY4/23 (¥ million) End-FY4/24 2Q (¥ million) Assets Liabilities and Net Assets Assets Liabilities and Net Assets Current Current Current assets 98,305 lia

  7. Slide 7: Assets

    Assets The balance of total assets increased ¥11,172 million from the end of the previous fiscal year because of increase in merchandise due to a rise in inventories of COVID-19 treatments, and an increase in buildings and structures due to the new store openings. (¥ million) End-FY4/23 2Q End-FY4/2

  8. Slide 8: Liabilities and Net Assets

    Liabilities and Net Assets Accounts payable increased ¥ 7,858 million due to increase in pharmaceutical inventories and new store openings. Short-term and long-term borrowings decreased ¥ 2,052 million due to repayment of loans payable. (¥ million) End-FY4/23 2Q End-FY4/23 End-FY4/24 2Q Change Accou

  9. Slide 9: Consolidated C/F

    Consolidated C/F Net cash provided by operating activities was ¥14,094 million due to increase in profits in both businesses. Because of that, cash and cash equivalents at end of the period increased ¥6,766 million from the previous year. The company maintained ample cash. (¥ million) FY4/23 2Q FY4/

  10. Slide 10: Business Value Analysis

    Business Value Analysis FY4/23 2Q FY4/23 FY4/24 2Q Change Shareholdersʼ equity ratio (%) 52.2 54.6 53.4 ＋1.2 Market value equity ratio (%) 94.9 85.5 61.3 (33.6) PER (times) 28.85 21.46 14.17 (14.68) EPS (¥) 108.32 262.87 149.66 ＋41.34 PBR (times) 1.83 1.58 1.16 (0.67) BPS (¥) 3,438.40 3,599.47 3,693

  11. Slide 11: FY4/24 Revised Plan (Consolidated)

    FY4/24 Revised Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2024 increase 8.8% YoY and ordinary profit increase 13.3% YoY due to new store openings of 41 stores for dispensing pharmacy business and 6 stores for cosmetic and drug store business. FY4/22 FY4/23

  12. Slide 12: Review

    Review © 2023 AIN HOLDINGS INC. All Rights Reserved. 11

  13. Slide 13: Review (YoY)

    Review (YoY) Ordinary profit increased ¥2.1 billion due to increase of net sales in dispensing pharmacy business and cosmetic and drug store business. Net sales Ordinary profit ¥171.2 billion → ¥193.7 billion +¥22.5 billion ¥7.2 billion → ¥9.3 billion +¥2.1 billion +28.2% +13.2% ■Dispensing Pharmacy

  14. Slide 14: Review (Plan)

    Review (Plan) Ordinary profit increased ¥2.9 billion due to increase of net sales in dispensing pharmacy business and cosmetic and drug store business. Net sales Ordinary profit ¥183.4 billion → ¥193.7 billion +¥10.3 billion ¥6.4 billion → ¥9.3 billion ＋¥2.9 billion +5.6% +45.4% ■Dispensing ■Dispens

  15. Slide 15: Revised plan

    Revised plan © 2023 AIN HOLDINGS INC. All Rights Reserved. 14

  16. Slide 16: FY4/24 Revised Plan (Dispensing Pharmacy Business)

    FY4/24 Revised Plan (Dispensing Pharmacy Business) The group revised the full-year consolidated financial forecasts because net sales of same stores and stores openings in the previous year expected to increase. Net sales were revised to ¥349,100 million, increased 8.6% YoY and 3.9% against the init

  17. Slide 17: FY4/24 Revised Plan (Cosmetic and Drug Store Business)

    FY4/24 Revised Plan (Cosmetic and Drug Store Business) The group revised the full-year consolidated financial forecasts because net sales expected to increase due to firm amid a recovery in mobility of customer numbers for same stores. Net sales were revised to ¥29,500 million, increased 14.9% YoY a

  18. Slide 18: FY4/24 Revised Plan (Consolidated)

    FY4/24 Revised Plan (Consolidated) The group revised the full-year consolidated financial forecasts because net sales expected to increase in both dispensing pharmacy business and cosmetic and drag store business. Net sales revised to ¥390,263 million and increased 8.8% YoY and 4.1% against the init

  19. Slide 19: Strategy

    Strategy © 2023 AIN HOLDINGS INC. All Rights Reserved. 18

  20. Slide 20: Strategy

    Strategy Expansion of top-line ■Dispensing Pharmacy Plan to open 41 pharmacies（Organic 21, M&A 20） ■Cosmetic and Drug Store Plan to open 6 stores Recruiting and training of human resources ■Planning to hire 600 newly graduated pharmacists and 620 medical support staff ■Make field manager system and

  21. Slide 21: Expansion of top-line

    Expansion of top-line ■Dispensing Pharmacy Plan to open 41 pharmacies（Organic 21, M&A 20） ■Cosmetic and Drug Store Plan to open 6 stores FY4/24 2Q Results FY4/24 Revised Plan 112 1,295 1,322 17 Dispensing Dispensing Pharmacies 1,217 Pharmacies 1,240 Cosmetics and 78 Cosmetics and 82 162 Drug stores

  22. Slide 22: Expansion of top-line: openings and closures

    Expansion of top-line ■Dispensing Pharmacy Plan to open 41 pharmacies（Organic 21, M&A 20） ■Cosmetic and Drug Store Plan to open 6 stores ■ Plan and Results FY4/24 2Q FY4/24 Plan Results Revised Plan Dispensing Pharmacy 19 15 41 Organic 10 9 21 Opening M&A 9 6 20 Cosmetic and drug store 2 2 6 Total 2

  23. Slide 23: Recruiting and training of human resources

    Recruiting and training of human resources ■Planning to hire 600 newly graduated pharmacists and 620 medical support staff ■Make field manager system and supervisor system more established ■Training of human resources In April 2023, new 543 pharmacists has joined our group. We aim to hire, new 600 p

  24. Slide 24: Reinforcing the Group's business base

    Reinforcing the Groupʼs business base ■Improving the customer services by promoting digital transformation, such as official apps ■Promoting Sustainable Management We aim to establish a competitive advantage in the sector by reinforcing our business base and increasing profitability through digital

  25. Slide 25: Reinforcing the Group's business base

    Reinforcing the Groupʼs business base ■Improving the customer services by promoting digital transformation, such as official apps ■Promoting Sustainable Management We have conducted our corporate activities with common sense and ethics in order to realize our group statement of “the health and happi

  26. Slide 26: Reinforcing the Group's business base

    Reinforcing the Groupʼs business base ■Improving the customer services by promoting digital transformation, such as official apps ■Promoting Sustainable Management Within our Sustainability Committee, approximately 30 project teams are promoting cross-sectoral initiatives for each materiality. 5. En

  27. Slide 27: Expansion of AINZ&TULPE

    Expansion of AINZ&TULPE ■Opening stores in prime locations and medium and long term store opening strategy AINZ & TULPE plan to open in FY4/24 (Revised Plan) 6 stores COCONO SUSUKINO (Opened in Nov. 2023 ) Tokyo (Plan to open in Mar. 2024 ) COCOLIA TAMA CENTER (Opened in June 2023 ） YOKOHAMA PORTA （

  28. Slide 28: FY4/24 Revised Plan (Consolidated)

    FY4/24 Revised Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2024 increase 8.8% YoY and ordinary profit increase 13.3% YoY due to new store openings of 41 stores for dispensing pharmacy business and 6 stores for cosmetic and drug store business. FY4/22 FY4/23

  29. Slide 29: AIN HOLDINGS INC. Corporate Planning Division

    Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/corporate/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This d

  30. Slide 30: AIN GROUP

    AIN GROUP

AIN Holdings — Q2 FY4/24 Earnings Presentation on 6ix